RhoA signaling is widely reported to be dysregulated in Alzheimer’s disease (AD), but its therapeutic targeting demonstrated mixed outcomes. We hypothesize that the activation and inactivation states of RhoA and LIMK are different in the cortex and in subregions of hippocampus along the rostral-caudal dimensions.
Objective:
We intended to elucidate the plane and spatial dependent RhoA signaling in association with AD.
Methods:
We applied antibody pRhoA that recognizes an inactive state of RhoA (S188 phosphorylation) and antibody pLIMK against an active state of LIMK (T508 phosphorylation) to investigate RhoA signaling in wildtype (WT) and triple transgenic AD (3xTg-AD) mouse model. We prepared serial sections from the rostral to caudal coronal planes of the entire mouse brain followed by immunofluorescence staining with pRhoA and pLIMK antibodies.
Results:
Both pRhoA and pLIMK elicited a shift of expression pattern from rostral to caudal planes. Additionally, pRhoA demonstrated dynamic redistribution between the nucleus and cytoplasm. pLIMK did not show such nucleus and cytoplasm redistribution but the expression level was changed from rostral to caudal planes. At some planes, pRhoA showed an increasing trend in expression in the cortex but a decreasing trend in the dentate gyrus of the 3xTg-AD mouse hippocampus. pLIMK tends to decrease in the cortex but increase in the dentate gyrus of 3xTg-AD mouse hippocampus.
Conclusions:
RhoA activation is dysregulated in both human and mouse AD brains, and the RhoA-LIMK signaling axis reveals spatial dysregulation along the rostral-caudal plane dimensions.
ZareiM, BeckmannCF, BinnewijzendMA, SchoonheimMM, OghabianMA, Sanz-ArigitaEJ, ScheltensP, MatthewsPM, BarkhofF. (2013) Functional segmentation of the hippocampus in the healthy human brain and in Alzheimer’s disease. Neuroimage66, 28–35.
BosJL, RehmannH, WittinghoferA (2007) GEFs and GAPs: Critical elements in the control of small G proteins. Cell129, 865–877.
6.
Garcia-MataR, BoulterE, BurridgeK (2011) The ‘invisible hand’: Regulation of RHO GTPases by RHOGDIs. Nat Rev Mol Cell Biol12, 493–504.
7.
RexCS, ChenLY, SharmaA, LiuJ, BabayanAH, GallCM, LynchG (2009) Different Rho GTPase-dependent signaling pathways initiate sequential steps in the consolidation of long-term potentiation. J Cell Biol186, 85–97.
8.
NumanoF, InoueA, EnomotoM, ShinomiyaK, OkawaA, OkabeS (2009) Critical involvement of Rho GTPase activity in the efficient transplantation of neural stem cells into the injured spinal cord. Mol Brain2, 37.
9.
Arrazola SastreA, Luque MontoroM, Galvez-MartinP, LacerdaHM, LuciaAM, LlaveroF, ZugazaJL (2020) Small GTPases of the Ras and Rho families switch on/off signaling pathways in neurodegenerative diseases. Int J Mol Sci21, 6312.
10.
GarvalovBK, FlynnKC, NeukirchenD, MeynL, TeuschN, WuX, BrakebuschC, BamburgJR, BradkeF (2007) Cdc42 regulates cofilin during the establishment of neuronal polarity. J Neurosci27, 13117–13129.
11.
HallA, LalliG (2010) Rho and Ras GTPases in axon growth, guidance, and branching. Cold Spring Harb Perspect Biol2, a001818.
12.
KimIH, WangH, SoderlingSH, YasudaR (2014) Loss of Cdc42 leads to defects in synaptic plasticity and remote memory recall. Elife3, e02839.
13.
KitamuraY, TsuchiyaD, TakataK, ShibagakiK, TaniguchiT, SmithMA, PerryG, MikiH, TakenawaT, ShimohamaS (2003) Possible involvement of Wiskott-Aldrich syndrome protein family in aberrant neuronal sprouting in Alzheimer’s disease. Neurosci Lett346, 149–152.
14.
WangS, WatanabeT, NoritakeJ, FukataM, YoshimuraT, ItohN, HaradaT, NakagawaM, MatsuuraY, ArimuraN, KaibuchiK (2007) IQGAP3, a novel effector of Rac1 and Cdc42, regulates neurite outgrowth. J Cell Sci120, 567–577.
15.
StankiewiczTR, LinsemanDA (2014) Rho family GTPases: Key players in neuronal development, neuronal survival, and neurodegeneration. Front Cell Neurosci8, 314.
16.
StankiewiczTR, PenaC, BouchardRJ, LinsemanDA (2020) Dysregulation of Rac or Rho elicits death of motor neurons and activation of these GTPases is altered in the G93A mutant hSOD1 mouse model of amyotrophic lateral sclerosis. Neurobiol Dis136, 104743.
17.
LanzTA, CarterDB, MerchantKM (2003) Dendritic spine loss in the hippocampus of young PDAPP and Tg2576 mice and its prevention by the ApoE2 genotype. Neurobiol Dis13, 246–253.
18.
CheffSW, PriceDA, SchmittFA, DeKoskyST, MufsonEJ (2007) Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology68, 1501–1508.
19.
DeKoskyST, ScheffSW (1990) Synapse loss in frontal cortex biopsies in Alzheimer’s disease: Correlation with cognitive severity. Ann Neurol27, 457–464.
20.
SelkoeDJ (2002) Alzheimer’s disease is a synaptic failure. Science298, 789–791.
21.
HuesaG, BaltronsMA, Gomez-RamosP, MoranA, GarciaA, HidalgoJ, FrancesS, SantpereG, FerrerI, GaleaE (2010) Altered distribution of RhoA in Alzheimer’s disease and AbetaPP overexpressing mice. J Alzheimers Dis19, 37–56.
22.
AguilarBJ, ZhuY, LuQ (2017) Rho GTPases as therapeutic targets in Alzheimer’s disease. Alzheimers Res Ther9, 97.
BorinM, SaracenoC, CataniaM, LorenzettoE, PontelliV, PaterliniA, FostinelliS, AvesaniA, Di FedeG, ZanussoG, BenussiL, BinettiG, ZorzanS, GhidoniR, BuffelliM, BologninS (2018) Rac1 activation links tau hyperphosphorylation and Abeta dysmetabolism in Alzheimer’s disease. Acta Neuropathol Commun6, 61.
25.
SaracenoC, CataniaM, PaterliniA, FostinelliS, CianiM, ZanardiniR, BinettiG, Di FedeG, CaroppoP, BenussiL, GhidoniR, BologninS (2018) Altered expression of circulating Cdc42 in frontotemporal lobar degeneration. J Alzheimers Dis61, 1477–1483.
26.
SocodatoR, PortugalCC, CanedoT, RodriguesA, AlmeidaTO, HenriquesJF, VazSH, 7MagalhaesJ, SilvaCM, BaptistaFI, AlvesRL, Coelho-SantosV, SilvaAP, Paes-de-CarvalhoR, MagalhaesA, BrakebuschC, SebastiaoAM, SummavielleT, AmbrosioAF, RelvasJB (2020) Microglia dysfunction caused by the loss of Rhoa disrupts neuronal physiology and leads to neurodegeneration. Cell Rep31, 107796.
27.
VargheseF, BukhariAB, MalhotraR, DeA (2014) IHC Profiler: An open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples. PLoS One9, e96801.
28.
Allen Institute for Brain Science (2004) Allen Mouse Brain Atlas [dataset]. Available from mouse.brain-map.org. Allen Institute for Brain Science (2011). Allen Reference Atlas – Mouse Brain [brain atlas]. Available from atlas.brain-map.org.
29.
Ben ZablahY, ZhangH, GugusteaR, JiaZ (2021) LIM-kinases in synaptic plasticity, memory, and brain diseases. Cells10, 2079.
30.
M HooglandPV, Martinez-GarciaF, Vermeulen-VanderzeeE (1994) Are rostral and caudal parts of the hippocampus of the lizard Gekko gecko related to different types of behaviour?Eur J Morphol32, 275–278.
31.
WestMJ, ColemanPD, FloodDG, TroncosoJC (1994) Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer’s disease. Lancet344, 769–772.
32.
EvansTE, AdamsHHH, LicherS, WoltersFJ, van der LugtA, IkramMK, O’SullivanMJ, VernooijMW, IkramMA (2018) Subregional volumes of the hippocampus in relation to cognitive function and risk of dementia. Neuroimage178, 129–135.
33.
XiongG, MethenyH, JohnsonBN, CohenAS (2017) A comparison of different slicing planes in preservation of major hippocampal pathway fibers in the mouse. Front Neuroanat11, 107.
34.
MizusekiK, RoyerS, DibaK, BuzsakiG (2012) Activity dynamics and behavioral correlates of CA3 and CA1 hippocampal pyramidal neurons. Hippocampus22, 1659–1680.
35.
DongHW, SwansonLW, ChenL, FanselowMS, TogaAW (2009) Genomic-anatomic evidence for distinct functional domains in hippocampal field CA1. Proc Natl Acad Sci U S A106, 11794–11799.
Nik AkhtarS, BunnerWP, BrennanE, LuQ, SzatmariEM (2023) Crosstalk between the Rho and Rab family of small GTPases in neurodegenerative disorders. Front Cell Neurosci17, 1084769.
